Back

Dipeptidyl Peptidase-4 Inhibition to Prevent Calcific Aortic Valve Disease: Proof of Concept Study (DIP CAVD_POC)

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late Breaking Basic and Translational Science - Atherosclerosis and Aortic Stenosis Aortic Valve Stenosis ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Jae-Kwan Song

Asan Medical Center, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Heat Shock Protein 25 Immunotherapy Post-Menopause is Superior to Estradiol in Targeting Atherogenesis, Plasma Cholesterol and PCSK9 Levels
Professor E. O'Brien (Calgary, CA)
Slides Video
Presentation thumbnail
A novel CT-based radiotranscriptomic signature of perivascular fat improves cardiac risk prediction in the SCOT-HEART and CRISP-CT studies
Professor C. Antoniades (Oxford, GB)
Presentation thumbnail
Clonal hematopoiesis of indeterminate potential (CHIP) in patients with degenerative aortic valve stenosis: incidence, clinical correlates, and prognostic significance following TAVI
Doctor S. Mas-Peiro (Frankfurt, DE)
Slides Video
Presentation thumbnail
The tyrosine kinase inhibitor nilotinib inhibits discoidin domain receptor 2 in human aortic valves, increases aortic valve thickness and induces valvular interstitial cell calcification
Professor M. Back (Stockholm, SE)
Slides Video

Access the full session

Session thumbnail
Late Breaking Basic and Translational Science - Atherosclerosis and Aortic Stenosis

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources